vaccines

News

Glass Medicine Vials and botox, hualuronic, collagen or flu Syringe on a white background.

Pfizer, BioNTech's mRNA flu vaccine starts phase 3 testing

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy t

Views & Analysis

Dr. B: Expanding the business model from COVID vaccines to a...

Cyrus Massoumi, founder of Dr.

News

Merck makes circular RNA play with $3.5bn Orna alliance

Merck & Co has ramped up its involvement in the RNA category, partnering with US biotech Orna Therapeutics in a deal valued at up to $3.5 billion, including $150 million upfront.

News

COVID antibody declines prompts call for booster jabs ASAP

Figures from the UK Office for National Statistics (ONS) have revealed that the number of people with higher levels of COVID-19 antibodies in their blood is declining quickly – leading to c

News

Ex-GSK vaccine chief to lead new UK biotech Vicebio

GSK's former head of vaccines R&D – Dr Emmanuel Hanon – is heading up a new biotech called Vicebio that will go up against his former employer with a vaccine against respiratory syncyti

R&D

New countries stockpile antiviral TPOXX as monkeypox outbrea...

pharmaphorum editor in chief Jonah Comstock talks to Philip Gomez, CEO of Siga Technologies, about how his company’s antiviral drug can play a crucial role in addressing monkeypox cases.

Pfizer, BioNTech's mRNA flu vaccine starts phase 3 testing

Dr. B: Expanding the business model from COVID vaccines to a...

Merck makes circular RNA play with $3.5bn Orna alliance

COVID antibody declines prompts call for booster jabs ASAP

Ex-GSK vaccine chief to lead new UK biotech Vicebio

New countries stockpile antiviral TPOXX as monkeypox outbrea...

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

vaccines

Editor's Picks